| pubmed-article:17663690 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17663690 | lifeskim:mentions | umls-concept:C0008059 | lld:lifeskim |
| pubmed-article:17663690 | lifeskim:mentions | umls-concept:C0040732 | lld:lifeskim |
| pubmed-article:17663690 | lifeskim:mentions | umls-concept:C0006826 | lld:lifeskim |
| pubmed-article:17663690 | lifeskim:mentions | umls-concept:C0205054 | lld:lifeskim |
| pubmed-article:17663690 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:17663690 | lifeskim:mentions | umls-concept:C0205225 | lld:lifeskim |
| pubmed-article:17663690 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:17663690 | pubmed:dateCreated | 2007-7-31 | lld:pubmed |
| pubmed-article:17663690 | pubmed:abstractText | HBL and HCC are the most common hepatic malignancies in children. The role of OLT in children with HCC is still a matter of debate. The aim of this study was to review our experience of OLT for HCC. Medical records of patients (<18 yr) who underwent OLT for HCC were reviewed and compared to children who underwent OLT for HBL and for indications other than malignancy. There were 25 patients: HCC (10 cases) and HBL (15 cases). The actuarial patient survival for HCC at one and five yr was 100% and 83.3%, for the HBL group the survival was 86.7% at both one and five yr, and for indications (n=377) other than malignancy the patient survival for pediatric OLT at our center was 87.7% and 84.7% at one and five yr, respectively. The actuarial recurrence free survival at five yr was 83.3% for HCC and 66.8% for HBL. In conclusion, OLT is a good therapeutic modality for children with HCC and HBL. | lld:pubmed |
| pubmed-article:17663690 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17663690 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17663690 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17663690 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17663690 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17663690 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:17663690 | pubmed:issn | 1397-3142 | lld:pubmed |
| pubmed-article:17663690 | pubmed:author | pubmed-author:EsquivelCarlo... | lld:pubmed |
| pubmed-article:17663690 | pubmed:author | pubmed-author:CastilloRicar... | lld:pubmed |
| pubmed-article:17663690 | pubmed:author | pubmed-author:VanattaJason... | lld:pubmed |
| pubmed-article:17663690 | pubmed:author | pubmed-author:DahlGaryG | lld:pubmed |
| pubmed-article:17663690 | pubmed:author | pubmed-author:CoxKenneth... | lld:pubmed |
| pubmed-article:17663690 | pubmed:author | pubmed-author:BerquistWilli... | lld:pubmed |
| pubmed-article:17663690 | pubmed:author | pubmed-author:BeaunoyerMona... | lld:pubmed |
| pubmed-article:17663690 | pubmed:author | pubmed-author:OgiharaMakoto... | lld:pubmed |
| pubmed-article:17663690 | pubmed:author | pubmed-author:StrichartzDeb... | lld:pubmed |
| pubmed-article:17663690 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17663690 | pubmed:volume | 11 | lld:pubmed |
| pubmed-article:17663690 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17663690 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17663690 | pubmed:pagination | 655-60 | lld:pubmed |
| pubmed-article:17663690 | pubmed:dateRevised | 2008-5-15 | lld:pubmed |
| pubmed-article:17663690 | pubmed:meshHeading | pubmed-meshheading:17663690... | lld:pubmed |
| pubmed-article:17663690 | pubmed:meshHeading | pubmed-meshheading:17663690... | lld:pubmed |
| pubmed-article:17663690 | pubmed:meshHeading | pubmed-meshheading:17663690... | lld:pubmed |
| pubmed-article:17663690 | pubmed:meshHeading | pubmed-meshheading:17663690... | lld:pubmed |
| pubmed-article:17663690 | pubmed:meshHeading | pubmed-meshheading:17663690... | lld:pubmed |
| pubmed-article:17663690 | pubmed:meshHeading | pubmed-meshheading:17663690... | lld:pubmed |
| pubmed-article:17663690 | pubmed:meshHeading | pubmed-meshheading:17663690... | lld:pubmed |
| pubmed-article:17663690 | pubmed:meshHeading | pubmed-meshheading:17663690... | lld:pubmed |
| pubmed-article:17663690 | pubmed:meshHeading | pubmed-meshheading:17663690... | lld:pubmed |
| pubmed-article:17663690 | pubmed:meshHeading | pubmed-meshheading:17663690... | lld:pubmed |
| pubmed-article:17663690 | pubmed:meshHeading | pubmed-meshheading:17663690... | lld:pubmed |
| pubmed-article:17663690 | pubmed:meshHeading | pubmed-meshheading:17663690... | lld:pubmed |
| pubmed-article:17663690 | pubmed:meshHeading | pubmed-meshheading:17663690... | lld:pubmed |
| pubmed-article:17663690 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17663690 | pubmed:articleTitle | Outcomes of transplantation in children with primary hepatic malignancy. | lld:pubmed |
| pubmed-article:17663690 | pubmed:affiliation | Divisions of Transplantation, Lucile Salter Packard Children's Hospital and Stanford University School of Medicine, Stanford, CA 94304, USA. | lld:pubmed |
| pubmed-article:17663690 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17663690 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:17663690 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17663690 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17663690 | lld:pubmed |
